Should measles be eradicated?

BMJ

Volumn 316, Issue 7133, 1998, Pages 765-

  Cutts, F T ^a   Steinglass, R ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b The US Agency for Intl Devmt Basic Support for Institutionalising Child Survival Project   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ADOLESCENT; CHILD; COST BENEFIT ANALYSIS; DRUG SAFETY; ERADICATION THERAPY; HEALTH EDUCATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEASLES; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SHORT SURVEY; SOCIAL EVOLUTION; WORLD HEALTH ORGANIZATION;

AGE FACTORS; COST-BENEFIT ANALYSIS; HEALTH PRIORITIES; HUMANS; IMMUNIZATION PROGRAMS; INTERNATIONAL COOPERATION; MEASLES; MEASLES VACCINE; POVERTY AREAS; PSYCHOLOGY, SOCIAL; WORLD HEALTH;

EID: 0032492417     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.316.7133.765     Document Type: Article

References (23)

1. Global Programme for Vaccines and Immunisation. Progress of vaccine research and development and plan of activities—1996. Geneva: WHO, 1996.
2. Expanded Programme on Immunisation. Meeting on advances in measles elimination: conclusions and recommendations. Weekly Epidemiol Rec 1996;71:305-12.
3. Hopkins D.R. Hinman A.R. Koplan J.P. Lane J.M. The case for global measles eradication. Lancet 1982; 1: 1396-1398.
4. Cutts F.T. Markowitz L.E. Successes and failures in measles control. J Infect Dis 1994; 170: S1-10.
5. McLean A.R. After the honeymoon in measles control. Lancet 1995; 345: 272.
6. Cutts F.T. Henderson R.H. Clements C.J. Chen R.T. Patriarca P.A. Principles of measles control. Bull WHO 1991;69:1-7.
7. Gay N.J. Hesketh L.M. Morgan-Capner P. Miller E. Interpretation of sero-logical surveillance data for measles using mathematical models: implications for vaccine strategy. Epidemiol Infect 1995;115:139-156.
8. McLean A.R. Anderson R.M. Measles in developing countries. Part I.I. The predicted impact of mass vaccination. Epidemiol Infect 1987;100:419-441.
9. Mulholland K. Measles and pertussis in developing countries with good vaccine coverage. Lancet 1995;345:305-307.
10. De Quadros C.A. Olivé J.M. Hersh B.S. Strassburg M.A. Henderson D.A. Brandling-Bennett D. et al. Measles elimination in the Americas. Evolving strategies. JAMA 1996;275:224-229.
11. Loutan L. Paillard S. Measles in a west African nomadic community. Bull WHO 1992;70:741-744.
12. World Health Organisation, UNICEF. State of the world's vaccines and immunisation. Geneva: WHO, 1996: 1-161.
13. Steinglass R. Boyd D. Grabowsky M. Laghari A.G. Khan M.A. Qavi A et al. Safety, effectiveness and ease of use of a non-reusable syringe in a developing country immunisation programme. Bull WHO 1995;73:57-63.
14. Aylward B. Lloyd J. Zaffran M. McNair-Scott R. Evans P. Reducing the risk of unsafe injections in immunisation programmes: financial and operational implications of various injection technologies. Bull WHO 1995;73:531-540.
15. Cutts F.T. Clements C.J. Bennett J.V. Alternative routes of measles immunisation: a review. Biologicals 1997;25:323-338.
16. Fine PEM. Herd immunity: history, theory, practice. Epidemiol Rev 1993;15:265-302.
17. White C.C. Koplan J.P. Orenstein W.A. Benefits, risks and costs of immunisation for measles, mumps and rubella. Am J Public Health 1985;75:739-744.
18. Cutts F.T. Monteiro O. Tabard P. Cliff J. Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months. Bull WHO 1994;72:227-231.
19. Aaby P. Bukh J. Lisse I.M. Smits A.J. Severe measles in Sunderland, 1885: a European-African comparison of causes of severe infection. Int J Epidemiol 1986;15:101-107.
20. Aaby P. Samb B. Simondon F. Seck A.M.C. Knudsen K. Whittle H. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ 1995;311:481-485.
21. Nelson E.A.S. Yu L.M. Poverty focused assistance: new category of development aid. Lancet 1996;348:1642-1643.
22. Taylor C. Cutts F. Taylor M. Ethical dilemmas in current planning for polio eradication. Am J Public Health 1997;87:922-925.
23. Expanded Programme on Immunisation. Measles control in the W.H. African Region. Weekly Epidemiol Rec 1996;26:201-3.